Morning Overview on MSN
The FDA approved the first oral carbapenem, Utebzi, for stubborn urinary infections
Adults with complicated urinary tract infections, including kidney infections, now have an oral antibiotic option that ...
After keeping the faith when it failed in the Modify phase III trial in October 2021, Idorsia Ltd. now has a clear route to market for lucerastat, an oral therapy for Fabry disease.
Weight loss drugs are going oral. Two new medications taken by mouth can help trim body weight in people living with obesity, scientists report in two studies published September 16 and 17 in the New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results